About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 950658, 17 pages
http://dx.doi.org/10.1155/2012/950658
Review Article

Salinomycin as a Drug for Targeting Human Cancer Stem Cells

1Institute of Immunology, University of Heidelberg, Im Neuenheimer Feld 305, 69120 Heidelberg, Germany
2Center and Network for Targeted Oncology, Clinical Research Division, Muehlackerweg 8, 69239 Heidelberg, Germany

Received 23 August 2012; Accepted 4 October 2012

Academic Editor: Adam Huczynski

Copyright © 2012 Cord Naujokat and Roman Steinhart. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Jacek Rutkowski, Izabela Borowicz, Joanna Wietrzyk, Ewa Maj, and Bogumil Brzezinski, “One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic-Lasalocid acid,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 18, pp. 5053–5056, 2013. View at Publisher · View at Google Scholar
  • Won Duk Joo, Irene Visintin, and Gil Mor, “Targeted cancer therapy – Are the days of systemic chemotherapy numbered?,” Maturitas, 2013. View at Publisher · View at Google Scholar
  • José N. Onuchic, Patricia A. Jennings, and Eshel Ben-Jacob, “Learning from cancer how to defeat bacteria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 9, pp. 3212–3213, 2013. View at Publisher · View at Google Scholar
  • Justin M. David, Tori A. Owens, and Sonali P. Barwe, “Gramicidin A Induces Metabolic Dysfunction and Energy Depletion Leading to Cell Death in Renal Cell Carcinoma Cells,” Molecular Cancer Therapeutics, vol. 12, no. 11, pp. 2296–2307, 2013. View at Publisher · View at Google Scholar
  • Petra Huehnchen, and Matthias Endres, “Assessment of Paclitaxel Induced Sensory Polyneuropathy with "Catwalk" Auto mated Gait Analysis in Mice,” Plos One, vol. 8, no. 10, 2013. View at Publisher · View at Google Scholar
  • Olajumoke Omolara Ojo, and Smrati Bhadauria, “Dose-Dependent Adverse Effects of Salinomycin on Male Reproductive Organs a nd Fertility in Mice,” Plos One, vol. 8, no. 7, 2013. View at Publisher · View at Google Scholar
  • Björn Borgström, Xiaoli Huang, Martin Pošta, Cecilia Hegardt, Stina Oredsson, and Daniel Strand, “Synthetic modification of salinomycin: selective O-acylation and biological evaluation,” Chemical Communications, vol. 49, no. 85, pp. 9944, 2013. View at Publisher · View at Google Scholar
  • Yonghe Li, Pui Kai Li, Michael J. Roberts, Rebecca Arend, Rajeev S. Samant, and Donald J. Buchsbaum, “Multi-targeted therapy of cancer by niclosamide: A new application for an old drug,” Cancer Letters, 2014. View at Publisher · View at Google Scholar
  • Susan D. Mertins, “Cancer stem cells,” Anti-Cancer Drugs, vol. 25, no. 4, pp. 353–367, 2014. View at Publisher · View at Google Scholar
  • Florian Kopp, Adam Hermawan, Prajakta Shirish Oak, Annika Herrmann, and Ernst Wagner, “Salinomycin treatment reduces metastatic tumor burden by hampering cancer c ell migration,” Molecular Cancer, vol. 13, 2014. View at Publisher · View at Google Scholar
  • Roberto Würth, Federica Barbieri, and Tullio Florio, “New Molecules and Old Drugs as Emerging Approaches to Selectively Target Human Glioblastoma Cancer Stem Cells,” BioMed Research International, vol. 2014, pp. 1–11, 2014. View at Publisher · View at Google Scholar